Globus Medical, Inc.

Globus Medical, Inc.

GMEDยทNYSE

$77.95

-0.38%
HealthcareMedical - Devices

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue-based products. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

At a Glance

Live Snapshot
Market Cap$10.51B
EPS3.9800
P/E Ratio19.59
Earnings Date07/30/2026
3Y+155.0%
5Y+216.0%
10Y+472.0%
3Y+218.0%
5Y+321.0%
10Y+663.0%
3Y+148.0%
5Y+204.0%
10Y+450.0%
gmed

Globus Medical, Inc. Funding & Solvency Profile

GMED ยท NYSE
Cash & Cash Equivalents526.16M
Net Receivables678.94M
Inventory759.28M
Other Current Assets130.15M
Total Current Assets2 B
Property, Plant & Equipment628.24M
Goodwill & Intangible Assets2.18B
Long-Term Investments0.00
Other Non-Current Assets150.60M
Total Non-Current Assets779 M
Total Assets
5.30B

Financial Health Analysis

Current Ratio

4.26x

Excellent liquidity position. The company can easily cover its short-term obligations with substantial cushion.

Debt-to-Equity Ratio

0.16x

Conservative capital structure. The company relies primarily on equity financing, indicating low financial risk.

Working Capital

2 B

Strong working capital position provides significant operational flexibility and financial cushion.

Asset Composition

40% Current

Balanced asset mix between current and non-current assets, typical of many stable businesses.

Financial Health Insight

Strong financial foundation: Excellent liquidity combined with conservative leverage suggests the company is well-positioned to weather economic uncertainties and fund growth opportunities.

Globus Medical, Inc. Balance Sheet

GMED โ€ข NYSE

Globus Medical, Inc. Balance SheetDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010
ASSETS
CURRENT ASSETS
526.2M
784.4M
467.3M
150.5M
193.1M
239.4M
195.7M
139.7M
118.8M
67M
60.2M
82.3M
90M
212.4M
142.7M
111.7M
31.1M
105.6M
50.5M
295.6M
250.4M
187.3M
115.8M
199.9M
254.9M
223.4M
220.9M
146.4M
149M
0.0
0.0
0.0
557.2M
890.1M
517.8M
446.1M
443.4M
426.7M
311.5M
339.7M
373.7M
290.3M
281M
228.7M
238.9M
212.4M
142.7M
111.7M
678.9M
578.3M
504.9M
217.3M
165.7M
148.1M
162.4M
144.4M
127.1M
95.8M
86.4M
81.2M
65.1M
58.6M
50.1M
48.6M
678.9M
557.7M
503.2M
213.2M
164.4M
141.7M
154.3M
137.1M
116.7M
92M
77.7M
75.4M
62.4M
53.5M
46.7M
42.4M
0.0
20.6M
1.6M
4.1M
1.2M
6.4M
8.1M
7.3M
10.4M
3.8M
8.7M
5.8M
2.7M
5.1M
3.3M
6.2M
759.3M
659.2M
848.1M
299M
237M
229.2M
196.3M
131.3M
108.4M
112.7M
105.3M
90.9M
70.4M
62.3M
47.4M
40.9M
0.0
0.0
0.0
0.0
18.4M
17.8M
17.2M
15.4M
11.2M
14.5M
7.4M
5.7M
5.1M
3M
2.5M
2.3M
130.2M
49.6M
44.6M
21M
0.0
0.0
0.0
100K
0.0
477K
64.8M
63.4M
37.3M
23.8M
16.2M
15.5M
2.1B
2.2B
1.9B
983.3M
864.5M
821.8M
687.5M
630.7M
620.3M
513.8M
544.8M
470M
416.8M
360.1M
258.8M
219M
NON-CURRENT ASSETS
628.2M
611.6M
646.9M
243.7M
221.1M
216.9M
199.8M
171.9M
143.2M
124.2M
114.7M
69.5M
64.2M
61.1M
52.4M
45.9M
1.4B
1.4B
1.4B
197.5M
179.7M
156.7M
128.8M
123.7M
123.9M
105.9M
92M
53.2M
18.4M
15.4M
9.8M
0.0
745.1M
795.1M
924.6M
63.6M
68.7M
86.9M
78.8M
87.3M
78.7M
61.7M
33.2M
34.5M
29.5M
9.6M
7.4M
0.0
2.2B
2.2B
2.4B
261M
248.4M
243.7M
207.6M
211.1M
202.5M
167.6M
125.2M
87.7M
47.9M
25M
17.2M
0.0
0.0
66.1M
75.4M
495.9M
562.5M
358.5M
409.5M
263.1M
56.1M
60.4M
48.8M
75.3M
36.5M
-23.8M
0.0
0.0
218.2M
94.2M
10.7M
48.8M
24.5M
6.6M
5.9M
13.6M
20M
30.6M
38.7M
40.1M
37.3M
23.8M
0.0
0.0
150.6M
75.1M
78.6M
43.3M
36.3M
32M
21.7M
10.4M
36.3M
30.9M
-38.1M
-39.1M
-36.4M
977K
980K
1.7M
3.2B
3.1B
3.2B
1.1B
1.1B
857.7M
844.6M
670M
458.2M
413.9M
289.3M
233.5M
149.5M
87M
70.6M
47.6M
5.3B
5.3B
5.1B
2.1B
2B
1.7B
1.5B
1.3B
1.1B
927.6M
834.1M
703.5M
566.3M
447.1M
329.4M
266.6M
LIABILITIES
CURRENT LIABILITIES
98.9M
119.9M
84.2M
47.1M
31.6M
33.5M
41M
30.4M
34.6M
26.3M
23.5M
26.6M
18M
13.5M
6.8M
7.7M
98.9M
75.1M
56.7M
36.1M
22M
18.2M
24.6M
25.9M
25M
17.5M
16M
21.3M
12.7M
12.5M
6.5M
7.3M
0.0
44.8M
27.6M
11M
9.7M
15.3M
16.4M
4.5M
9.6M
8.9M
7.6M
5.3M
5.3M
996K
302K
427K
0.0
74.7M
75.9M
28.8M
32.3M
28.4M
21.1M
23.8M
17.3M
16.2M
25.8M
36.8M
30.8M
7.8M
8.1M
7.9M
14.7M
443.4M
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
5.3M
0.0
10.2M
12M
2.5M
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
4.2M
44.8M
27.6M
11M
7.5M
6.1M
6.1M
4.5M
9.6M
8.9M
7.6M
5.3M
5.3M
996K
302K
427K
27.7M
22.1M
18.4M
14.1M
12M
8.1M
5.4M
2.6M
755K
0.0
0.0
0.0
0.0
0.0
0.0
0.0
357.3M
185.6M
201.9M
66.7M
64.2M
50.7M
43.9M
39.3M
40.4M
37.3M
33.3M
26M
19.2M
18.2M
14.3M
10.9M
498.5M
855.9M
392.3M
159.2M
140.2M
120.8M
111.4M
96.1M
93.1M
79.9M
82.7M
89.4M
67.9M
39.5M
29.3M
31.7M
NON-CURRENT LIABILITIES
103.9M
0.0
417.4M
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
23.8M
23.9M
84.4M
1.8M
4.3M
6.2M
6M
8.1M
10.7M
7.9M
13.3M
5.2M
6.4M
7.7M
5.8M
2.8M
103.3M
111M
102.9M
65.3M
71.4M
46.2M
12.2M
10.9M
7M
7.8M
22.8M
23.5M
19.6M
13.4M
11.9M
3.8M
231M
218.5M
695.8M
70.5M
75.7M
52.4M
18.2M
19M
17.7M
15.7M
36.1M
28.7M
26M
21.1M
17.6M
6.7M
0.0
93.8M
103M
6M
0.0
0.0
1.1M
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
729.5M
1.1B
1.1B
229.8M
215.9M
173.2M
129.6M
115.2M
110.7M
95.6M
118.8M
118.1M
93.9M
60.6M
46.9M
38.4M
SHAREHOLDERS' EQUITY
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
51K
51K
135K
137K
136K
100K
101K
99K
99K
98K
97K
96K
95K
95K
93K
91K
73K
74K
0.0
3B
2.9B
631M
553.8M
457.2M
357.3M
299.9M
238.3M
211.7M
192.6M
175.2M
154M
136.5M
106.7M
102.7M
1.4B
1.2B
1.1B
1.2B
1.2B
1B
1B
892.7M
736.2M
628.9M
524.6M
411.8M
319.3M
250.7M
176.8M
126.1M
15.3M
-6.9M
-10.2M
-24.6M
-6.8M
4M
-2.9M
-7.2M
-6.9M
-8.6M
-2M
-1.7M
-1M
-767K
-1.2M
-718K
3.2B
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
4.6B
4.2B
4B
1.8B
1.7B
1.5B
1.4B
1.2B
967.8M
832.1M
715.3M
585.5M
472.4M
386.5M
282.5M
228.2M
4.6B
4.2B
4B
1.8B
1.7B
1.5B
1.4B
1.2B
967.8M
832.1M
715.3M
585.5M
472.4M
386.5M
282.5M
228.2M
SUMMARY
5.3B
5.3B
5.1B
2.1B
2B
1.7B
1.5B
1.3B
1.1B
927.6M
834.1M
703.5M
566.3M
447.1M
329.4M
266.6M
31.1M
171.8M
125.9M
791.4M
812.9M
545.9M
525.3M
463.1M
311M
283.8M
269.6M
221.8M
185.5M
-23.8M
0.0
0.0
118.7M
537.2M
520.4M
6M
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
5.3M
-407.5M
-247.3M
53.1M
-144.5M
-193.1M
-239.4M
-195.7M
-139.6M
-118.8M
-67M
-60.2M
-82.3M
-90M
-212.4M
-142.7M
-106.4M
133,832,422
133,832,422
133,832,422
133,832,422
133,832,422
133,832,422
133,832,422
133,832,422
133,832,422
133,832,422
133,832,422
133,832,422
133,832,422
133,832,422
133,832,422
133,832,422

SEC Filings

GMED - Filing history and reports

Filing TypeFiling DatePeriod EndingFiscal YearActions
10-Q

10-Q 2026 Q1

Q1

May 07, 2026
March 31, 2026
2026
8-K

8-K 2026

N/A

May 07, 2026
May 07, 2026
2026
DEF 14A

DEF 14A 2026

N/A

April 24, 2026
June 03, 2026
2026
8-K

8-K 2026

N/A

March 23, 2026
March 23, 2026
2026
8-K

8-K 2026

N/A

February 24, 2026
February 24, 2026
2026
10-K

10-K 2025 FY

FY

February 24, 2026
December 31, 2025
2025
8-K

8-K 2026

N/A

January 07, 2026
January 07, 2026
2026
10-Q

10-Q 2025 Q3

Q3

November 06, 2025
September 30, 2025
2025
8-K

8-K 2025

N/A

November 06, 2025
November 06, 2025
2025
10-Q

10-Q 2025 Q2

Q2

August 07, 2025
June 30, 2025
2025
Showing 1 to 10 of 210 filings